Stroke Trial, Recruiting NCT06726434 Sponsor: Poitiers University Hospital Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06726434
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older.
  • You have a foot condition called "spastic equinovarus foot" (where the foot turns inward and downward due to muscle stiffness) caused by a stroke that happened more than 6 months ago.
  • You had a specific nerve-blocking test done on your foot that showed a positive result, meeting certain movement criteria (confirm with trial site).
  • Your doctor has assessed that you are suitable for a surgical procedure on the nerves of your foot to treat the spasticity.
  • You do not have significant memory or thinking problems, or severe depression, based on standard tests (confirm with trial site).
  • You have no history of serious mental illness (such as psychosis) that required a hospital stay.
  • You are willing and able to follow the requirements of the study.
  • You are covered by French national health insurance.
  • You have been fully informed about the study and have given your written agreement to take part.

Who may not be able to join:

  • You have previously had nerve treatments such as alcohol injections, nerve freezing, or surgery at the same area of the body being studied.
  • You have a neurological condition other than the one causing your muscle stiffness.
  • You have received botulinum toxin (e.g. Botox) injections in your lower limb within the last 90 days before the procedure.
  • You have taken a muscle-relaxing medication called baclofen within 3 days before the nerve-blocking test.
  • You have a complete loss of function in certain muscles in your foot (confirm with trial site).
  • Your foot is fixed in a downward position by more than 40 degrees due to stiffness or joint changes.
  • You have medical reasons that make surgery or anaesthesia unsafe, such as a severe uncontrolled blood clotting disorder or an active infection.
  • You have certain health conditions that make nerve-freezing treatment unsafe, such as cold intolerance, specific blood protein disorders, Raynaud's phenomenon, recent blood clots, an underactive thyroid, cold-triggered allergic reactions, poor blood supply to the area, severe anaemia, very low body weight, low body temperature, cancer, or a blood clotting disorder (confirm with trial site for the full list).
  • You are a minor, pregnant, breastfeeding, or a woman of childbearing age not using effective contraception.
  • You are legally protected or under guardianship, detained by a court or administrative order, or living in a health or social care institution.
  • You are in an emergency medical situation.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33 5 49 44 44 54

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Poitiers University Hospital
Registry
ClinicalTrials.gov
Start date
9 July 2025
Est. completion
9 April 2029

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Mean absolute change in spasticity assessed by the Modified Ashworth Scale (MAS) ranging from 0 (no spasticity) to 4 (maximum spasticity).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov